Mir Varquez
Cardiovascular Disease · Cullman, ALNPI 1295776581
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for cardiovascular disease clinicians in AL, where the typical reported total is $2,733.
Across 166 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$576
- Novartis$443
- Amarin Pharma, Inc.$232
- Astellas Pharma US Inc$198
- Johnson & Johnson$187
- Amgen$183
- plus $935 from 16 others
What the payments were for
- Food & beverage$2,52292%
- Education$2318%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 44 | $576 |
| Novartis | 16 | $443 |
| Amarin Pharma, Inc. | 15 | $232 |
| Astellas Pharma US Inc | 2 | $198 |
| Johnson & Johnson | 15 | $187 |
| Amgen | 16 | $183 |
| AstraZeneca | 11 | $166 |
| Lundbeck LLC | 8 | $155 |
| Boehringer Ingelheim | 6 | $98 |
| Abbott | 4 | $88 |
| Kowa Pharmaceuticals America, Inc. | 6 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $58 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Genentech USA, Inc. | 3 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $31 |
| Galderma Laboratories, L.p. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Pfizer | 1 | $19 |
| Philips North America LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTRESTO$125
How this compares
$2,754 in reported general payments places this provider in the 50th percentile of 292 cardiovascular disease providers in Alabama.
Other cardiovascular disease in Cullman
- Dennis ThomasMobile$894K
- David FienoAlabaster$421K
- Vikram AroraBirmingham$271K
- Jason ThompsonBirmingham$248K
- Michael WilenskyBirmingham$241K
- Mustafa AhmedBirmingham$218K
- Frederick GaskinBirmingham$115K
- Pankaj AroraBirmingham$83K
- Ajit NaiduFlorence$66K
- Mahomed SalameAnniston$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.